This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulation 42ZCZS, this notice publishes:
A decision made by a delegate of the Secretary pursuant to regulations 42ZCZR
reasons for that final decision
date of effect of the decision.
Final decision in relation to amygdalin and hydrocyanic acid
Note that the final decision for amygdalin and hydrocyanic acid is not published in this notice. This decision has been delayed for further consultation.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.